28 July, 2021
Bioprofarma Bagó
Trabajando el presente, pensando el futuro.
Noticias relacionadas
New Product Launch NILTARA®nilotinib
Bioprofarma Bagó is pleased to present the launch of the product NILTARA® nilotinib, for its Hematology Line. This new product has been...
LACE Congress 2024
The Argentine League Against Epilepsy 2024 Congress took place on September 26th and 27th at the Palais Rouge. For the second...
61st Argentine Congress of Urology
The 61st Argentine Congress of Urology, organized by the Argentine Society of Urology, was held on September 4th, 5th, and...
Launch of UroControl®
On Tuesday, September 3rd, we launched a new product, UroControl®, an innovative test for the early detection of relapses in...
New Product Lunch IMPILO®bexarotene
Bioprofarma Bagó is pleased to introduce IMPILO® bexarotene, for its Hematology Line, replacing the historical TARGRETIN® bexarotene. Based on its...
26th ARGENTINE CONGRESS OF HEMATOLOGY organized by the Argentine Society of Hematology
Bioprofarma Bagó participated in the 26th Argentine Congress of Hematology 2023, which was held in November 1-4 at its two...
XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC
November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at the La Rural property, in...
New Product Launch VETRANO®palbociclib
We are thrilled to present to our community the launch of the product VETRANO® palbociclib, for our Oncology...
New Product Lunch TSUMIS®Carfilzomib
Bioprofarma Bagó is pleased to present the launch of the product TSUMIS® carfilzomib, for its Hematology Line. TSUMIS® carfilzomib...
